Matches in Wikidata for { <http://www.wikidata.org/entity/Q74602309> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q74602309 description "artikull shkencor i botuar më 01 janar 1999" @default.
- Q74602309 description "artículu científicu espublizáu en xineru de 1999" @default.
- Q74602309 description "im Januar 1999 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74602309 description "scientific article published on 01 January 1999" @default.
- Q74602309 description "wetenschappelijk artikel" @default.
- Q74602309 description "наукова стаття, опублікована в січні 1999" @default.
- Q74602309 name "Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group" @default.
- Q74602309 name "Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group" @default.
- Q74602309 name "Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group" @default.
- Q74602309 type Item @default.
- Q74602309 label "Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group" @default.
- Q74602309 label "Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group" @default.
- Q74602309 label "Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group" @default.
- Q74602309 prefLabel "Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group" @default.
- Q74602309 prefLabel "Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group" @default.
- Q74602309 prefLabel "Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group" @default.
- Q74602309 P1433 Q74602309-3F236865-39BB-4CD6-9A2B-87D7DDB8BCB3 @default.
- Q74602309 P1476 Q74602309-3E7C4845-B0B5-4209-B348-37CA933CA2FD @default.
- Q74602309 P2093 Q74602309-667BA0FA-981E-4F98-AFA3-451862EAFD42 @default.
- Q74602309 P2093 Q74602309-8D484675-A845-41BE-8A4B-09B8CFEAC39E @default.
- Q74602309 P2093 Q74602309-9100909C-52FE-4037-91D6-FD2789D471D2 @default.
- Q74602309 P304 Q74602309-4C5FDCAF-4D07-4EF5-9E0F-B46D6B638619 @default.
- Q74602309 P31 Q74602309-981FAA2F-EE2E-44BD-AC10-36DC7A8C295E @default.
- Q74602309 P356 Q74602309-E7C8EB4F-777D-4D9A-8A26-FB5FF96B8BBF @default.
- Q74602309 P407 Q74602309-85A5EF3A-0A29-48A4-BC34-5F812CDA6202 @default.
- Q74602309 P433 Q74602309-4900DA7A-2723-4523-82C4-5384D06CBD89 @default.
- Q74602309 P478 Q74602309-EBC1C1FD-36DC-4445-A5B2-A926974355D3 @default.
- Q74602309 P577 Q74602309-020872E7-5812-4CA0-81A3-E49B9B97574B @default.
- Q74602309 P698 Q74602309-4146D716-949F-4F8A-A0EE-D7F64698C24E @default.
- Q74602309 P921 Q74602309-6D2B60C4-2F35-4418-859C-54B752115C51 @default.
- Q74602309 P356 00007890-199901270-00016 @default.
- Q74602309 P698 10075594 @default.
- Q74602309 P1433 Q15730500 @default.
- Q74602309 P1476 "Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group" @default.
- Q74602309 P2093 "B D Kahan" @default.
- Q74602309 P2093 "M Hall" @default.
- Q74602309 P2093 "P R Rajagopalan" @default.
- Q74602309 P304 "276-284" @default.
- Q74602309 P31 Q13442814 @default.
- Q74602309 P356 "10.1097/00007890-199901270-00016" @default.
- Q74602309 P407 Q1860 @default.
- Q74602309 P433 "2" @default.
- Q74602309 P478 "67" @default.
- Q74602309 P577 "1999-01-01T00:00:00Z" @default.
- Q74602309 P698 "10075594" @default.
- Q74602309 P921 Q422248 @default.